DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on November 10 for the period ending September 30 2025
The New York City-based company is expected to report a 49.7% decrease in revenue to $69.77 million from $138.68 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for DocGo Inc is for a loss of 12 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DocGo Inc is $3.00, about 64.3% above its last closing price of $1.07
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -0.10 | -0.09 | -0.11 | Missed | -16.7 |
Mar. 31 2025 | -0.03 | -0.02 | -0.09 | Missed | -320 |
Dec. 31 2024 | 0.04 | 0.05 | 0.04 | Missed | -17.6 |
Sep. 30 2024 | 0.04 | 0.05 | 0.05 | Met | 2.9 |
Jun. 30 2024 | 0.06 | 0.08 | 0.07 | Missed | -6.7 |
Mar. 31 2024 | 0.07 | 0.08 | 0.10 | Beat | 22.8 |
Dec. 31 2023 | 0.09 | 0.10 | 0.07 | Missed | -30 |
Sep. 30 2023 | 0.05 | 0.06 | 0.05 | Missed | -18.9 |
This summary was machine generated November 7 at 22:49 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)